Global leader in critical care and alternative care medical products selects Global 2.0 to manage its medical device approvals and submissions worldwide.
Framingham, MA, April 1, 2004 – clinivation, Inc. today announced Medex, Inc. has selected clinivation Global™ 2.0 software.
“Medex is clearly a global leader in the development of critical care medical products used in acute and alternative care settings, and we are pleased they have selected clinivation Global 2.0 to help them build and track their medical device approvals and submissions worldwide,” said Joseph Kozikowski, M.D., clinivation’s Founder, Chairman, and Chief Executive Officer
Clinivation Global 2.0 software enables medical device companies to sell more products to more countries faster and easier than ever before. Global 2.0 is the first complete solution targeted at automating the business processes for medical device approvals worldwide.
About Medex, Inc.
Medex is a global manufacturer and marketer of critical care and alternate care medical products used in both acute and alternate care settings for a variety of therapeutic, diagnostic and long-term procedures. Medex markets and sells critical care systems and products to over 5,500 hospitals, health care systems, and alternate healthcare settings in more than 75 countries through a global sales force and distribution network. Headquartered in Carlsbad, California, the Company employs approximately 2,000 people worldwide.
For more information, please visit www.medex.com
